Shares of Goldman Sachs and Morgan Stanley fell Wednesday despite stronger-than-expected profit from the two big banks, as investors saw little reason to bid up equity prices further after gains in ...

Retail chatter around Apellis Pharmaceuticals spiked Thursday after Goldman Sachs raised its price target to $26 from $24, citing strong quarterly performance and long-term growth potential through ...

Goldman Sachs' Q2 2025 results validate its strategic shift to core businesses, with improved margins. Read why I rate GS ...

The bank led a broad surge in trading revenue across Wall Street in the second quarter, fueled by the market volatility set ...

Goldman Sachs, Bank of America, and Morgan Stanley just dropped their Q2 earnings numbers, and let’s be honest, Wall Street analysts got smoked. All three ...

Goldman Sachs reported a significant 20% surge in net profit for the second quarter of 2025, reaching $3.5 billion, fueled by ...

A Goldman Sachs executive is outlining potentially tactical stock trades as second-quarter earnings reports begin to roll out in mid-July.

The bank’s net earnings applicable to common shareholders rose 2% to $2.25 billion in the quarter ended June 30. Earnings per share rose to $6.26 from $5.81 a year earlier.

Goldman Sachs, Morgan Stanley earnings beats were fueled by trading surge as deal pipelines grow Equities-trading revenue at Goldman climbs 36% to $4.3 billion, while Morgan Stanley’s profit ...